126 related articles for article (PubMed ID: 35880128)
1. An
Liang YC; Berton S; Reeks C; Sun J
STAR Protoc; 2022 Sep; 3(3):101575. PubMed ID: 35880128
[TBL] [Abstract][Full Text] [Related]
2. Rational Design of Biosafety Level 2-Approved, Multidrug-Resistant Strains of Mycobacterium tuberculosis through Nutrient Auxotrophy.
Vilchèze C; Copeland J; Keiser TL; Weisbrod T; Washington J; Jain P; Malek A; Weinrick B; Jacobs WR
mBio; 2018 May; 9(3):. PubMed ID: 29844114
[TBL] [Abstract][Full Text] [Related]
3. A novel biosafety level 2 compliant tuberculosis infection model using a Δ
Asai M; Li Y; Spiropoulos J; Cooley W; Everest D; Robertson BD; Langford PR; Newton SM
Virulence; 2020 Dec; 11(1):811-824. PubMed ID: 32530737
[TBL] [Abstract][Full Text] [Related]
4. Xpert MTB/RIF and Xpert MTB/RIF Ultra assays for active tuberculosis and rifampicin resistance in children.
Kay AW; González Fernández L; Takwoingi Y; Eisenhut M; Detjen AK; Steingart KR; Mandalakas AM
Cochrane Database Syst Rev; 2020 Aug; 8(8):CD013359. PubMed ID: 32853411
[TBL] [Abstract][Full Text] [Related]
5. The Application of Xpert Mycobacterium tuberculosis/Rifampicin, Quantitative Polymerase Chain Reaction and High Resolution Melting Curve in the Diagnosis of Superficial Lymph Node TB.
Han Y; Xiao N; Huang S; Qin M; Che N; Liu Z
Curr Pharm Biotechnol; 2019; 20(12):1044-1054. PubMed ID: 31333119
[TBL] [Abstract][Full Text] [Related]
6. Use of RODAC plates to measure containment of Mycobacterium tuberculosis in a Class IIB biosafety cabinet during routine operations.
Daneau G; Nduwamahoro E; Fissette K; Rüdelsheim P; van Soolingen D; de Jong BC; Rigouts L
Int J Mycobacteriol; 2016 Jun; 5(2):148-54. PubMed ID: 27242225
[TBL] [Abstract][Full Text] [Related]
7. A New Screen for Tuberculosis Drug Candidates Utilizing a Luciferase-Expressing Recombinant Mycobacterium bovis Bacillus Calmette-Guéren.
Ozeki Y; Igarashi M; Doe M; Tamaru A; Kinoshita N; Ogura Y; Iwamoto T; Sawa R; Umekita M; Enany S; Nishiuchi Y; Osada-Oka M; Hayashi T; Niki M; Tateishi Y; Hatano M; Matsumoto S
PLoS One; 2015; 10(11):e0141658. PubMed ID: 26571296
[TBL] [Abstract][Full Text] [Related]
8. Click-chemistry-based protocol to quantitatively assess fatty acid uptake by Mycobacterium tuberculosis in axenic culture and inside mouse macrophages.
Laval T; Demangel C
STAR Protoc; 2023 Mar; 4(1):102062. PubMed ID: 36853675
[TBL] [Abstract][Full Text] [Related]
9. Protocol for multi-modal single-cell RNA sequencing on M. tuberculosis-infected mouse lungs.
Pisu D; Russell DG
STAR Protoc; 2023 Mar; 4(1):102102. PubMed ID: 36853694
[TBL] [Abstract][Full Text] [Related]
10. Dual RNA-Sequencing of
Pisu D; Huang L; Rin Lee BN; Grenier JK; Russell DG
STAR Protoc; 2020 Dec; 1(3):100123. PubMed ID: 33377017
[TBL] [Abstract][Full Text] [Related]
11. Thin-Layer-Agar-Based Direct Phenotypic Drug Susceptibility Testing on Sputum in Eswatini Rapidly Detects Mycobacterium tuberculosis Growth and Rifampicin Resistance Otherwise Missed by WHO-Endorsed Diagnostic Tests.
Ardizzoni E; Ariza E; Mulengwa D; Mpala Q; de La Tour R; Maphalala G; Varaine F; Kerschberger B; Graulus P; Page AL; Niemann S; Dreyer V; Van Deun A; Decroo T; Rigouts L; de Jong BC
Antimicrob Agents Chemother; 2021 May; 65(6):. PubMed ID: 33722892
[TBL] [Abstract][Full Text] [Related]
12. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
13. Liquid chromatography-mass spectrometry-based protocol to measure drug accumulation in Mycobacterium tuberculosis and its host cell.
Ahn YM; Lavin RC; Tan S; Freundlich JS
STAR Protoc; 2023 Mar; 4(1):101971. PubMed ID: 36598855
[TBL] [Abstract][Full Text] [Related]
14. Analyzing human CD4
Gail DP; Suzart VG; Carpenter SM
STAR Protoc; 2024 Mar; 5(1):102939. PubMed ID: 38451821
[TBL] [Abstract][Full Text] [Related]
15. Protocol for
Naz S; Dabral S; Kumar D; Nandicoori VK
STAR Protoc; 2022 Dec; 3(4):101804. PubMed ID: 36340884
[TBL] [Abstract][Full Text] [Related]
16.
Heinrichs MT; May RJ; Heider F; Reimers T; B Sy SK; Peloquin CA; Derendorf H
Int J Mycobacteriol; 2018; 7(2):156-161. PubMed ID: 29900893
[TBL] [Abstract][Full Text] [Related]
17. Application of Mycobacterium smegmatis as a surrogate to evaluate drug leads against Mycobacterium tuberculosis.
Lelovic N; Mitachi K; Yang J; Lemieux MR; Ji Y; Kurosu M
J Antibiot (Tokyo); 2020 Nov; 73(11):780-789. PubMed ID: 32472054
[TBL] [Abstract][Full Text] [Related]
18. Clinical Evaluation of a Line-Probe Assay for Tuberculosis Detection and Drug-Resistance Prediction in Namibia.
Günther G; Saathoff E; Rachow A; Ekandjo H; Diergaardt A; Marais N; Lange C; Nepolo E
Microbiol Spectr; 2022 Jun; 10(3):e0025922. PubMed ID: 35670620
[TBL] [Abstract][Full Text] [Related]
19. Medium throughput protocol for genome-based quantification of intracellular mycobacterial loads and macrophage survival during
Yabaji SM; Chatterjee S; Waligursky E; Gimelbrant A; Kramnik I
STAR Protoc; 2022 Jun; 3(2):101241. PubMed ID: 35310069
[TBL] [Abstract][Full Text] [Related]
20. Practical biosafety in the tuberculosis laboratory: containment at the source is what truly counts.
van Soolingen D; Wisselink HJ; Lumb R; Anthony R; van der Zanden A; Gilpin C
Int J Tuberc Lung Dis; 2014 Aug; 18(8):885-9. PubMed ID: 25199000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
